Cargando…
Association between Circulating Levels of 25-Hydroxyvitamin D(3) and Matrix Metalloproteinase-10 (MMP-10) in Patients with Type 2 Diabetes
Background: Matrix metalloproteinase-10 (MMP-10) levels increase progressively starting from early diabetic kidney disease (DKD) stages. Vitamin D(3) (vitD(3)) deficit is associated with a higher risk of diabetic microangiopathy. Reduced MMP-10 expression has been observed after exposure to vitD(3)....
Autores principales: | Abasheva, Daria, Dolcet-Negre, Marta M., Fernández-Seara, María A., Mora-Gutiérrez, José María, Orbe, Josune, Escalada, Francisco Javier, Garcia-Fernandez, Nuria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458174/ https://www.ncbi.nlm.nih.gov/pubmed/36079742 http://dx.doi.org/10.3390/nu14173484 |
Ejemplares similares
-
MMP-10 is Increased in Early Stage Diabetic Kidney Disease and can be Reduced by Renin-Angiotensin System Blockade
por: Mora-Gutiérrez, José María, et al.
Publicado: (2020) -
Matrix Metalloproteinases in Diabetic Kidney Disease
por: Garcia-Fernandez, Nuria, et al.
Publicado: (2020) -
Matrix Metalloproteinase 10 Contributes to Choroidal Neovascularisation
por: González-Zamora, Jorge, et al.
Publicado: (2022) -
Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2009) -
Enhanced Expression but Decreased Specific Activity of Matrix Metalloproteinase 10 (MMP-10) in Comparison with Matrix Metalloproteinase 3 (MMP-3) in Human Urinary Bladder Carcinoma
por: Kudelski, Jacek, et al.
Publicado: (2021)